Correlations between the Sonic Hedgehog Pathway and basal cell carcinoma

International Journal of Dermatology

Volumn 46, Issue 11, 2007, Pages 1113-1117

  Lupi, Omar ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPAMINE; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN PATCHED; SONIC HEDGEHOG PROTEIN;

ANTINEOPLASTIC ACTIVITY; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMOPROPHYLAXIS; CORRELATION ANALYSIS; DISEASE MODEL; FAMILIAL CANCER; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; NONHUMAN; PROTEIN FUNCTION; REVIEW; SKIN CARCINOGENESIS;

ANIMALS; CARCINOMA, BASAL CELL; CELL TRANSFORMATION, NEOPLASTIC; FORKHEAD TRANSCRIPTION FACTORS; HEDGEHOG PROTEINS; HUMANS; MUTATION; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; VERATRUM ALKALOIDS;

EID: 35848929300     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03391.x     Document Type: Review

References (35)

1. Murone M, Rosenthal A, De-Sauvage FJ. Hedgehog signal transduction from flies to vertebrates. Exp Cell Res 1999; 253: 25-33.
2. Hahn H, Wojnowski L, Miller G, et al. The patched signaling pathway in tumorigenesis and development: Lessons from animal models. J Mol Med 1999; 77: 459-468.
3. Couve-Privat S, Bouadjar B, Avril MF, et al. Significantly high levels of ultraviolet-specific mutations in the smoothened gene in basal cell carcinomas from DNA repair-deficient xeroderma pigmentosum patients. Cancer Res 2002; 62: 7186-7189.
4. Bale AE. Hedgehog signaling and human disease. Annu Rev Genomics Hum Genet 2002; 3: 47-65.
5. Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet 2001; 10: 757-762.
6. Nilsson M, Unden AB, Krause D. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing Gli-1. Proc Natl Acad Sci USA 2000; 97: 3438-3443.
7. Rahnama F, Toftgard R, Zaphiropoulos PG. Distinct roles of PTCH-2 splice variants in Hedgehog signalling. Biochem J 2004; 378 (Pt 2): 325-334.
8. Lee Y, Miller HL, Russell HR, et al. Patched 2 modulates tumorigenesis in patched 1 heterozygous mice. Cancer Res 2006; 66: 6964-6971.
9. Athar M, Tang X, Lee JL, et al. Hedgehog signalling in skin development and cancer. Exp Dermatol 2006; 15: 667-677.
10. Tojo M, Kiyosawa H, Iwatsuki K, et al. Expression of a sonic hedgehog signal transducer, hedgehog-interacting protein, by human basal cell carcinoma. Br J Dermatol 2002; 146: 69-73.
11. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996; 85: 841-851.
12. Gailani MR, Stahle-Backdahl M, Leffell DJ, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinoma. Nat Genet 1996; 14: 78-81.
13. Oro AE, Higgins KM, Hu Z, et al. Basal cell carcinomas overexpressing Sonic Hedgehog. Science 1997; 276: 817-821.
14. Zedan W, Robinson PA, Markam AF, et al. Expression of the Sonic Hedgehog receptor "PATCHED" in basal cell carcinomas and odontogenic keratocysts. J Pathol 2001; 194: 473-477.
15. Fan H, Oro AE, Scott MP, et al. Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog. Nat Med 1997; 3: 788-792.
16. Hardy MH. The secret life of the hair follicle. Trends Genet 1992; 8: 55-61.
17. Lupi O. Sindrome do nevo basocelular. In: Neves RG, Lupi O, Talhari S, eds. Câncer da Pele. Rio de Janeiro: Ed Medsi, 2001: 85-93.
18. Sands AT, Abuin A, Sanchez A, et al. High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 1995; 377: 162-165.
19. Fan H, Khavari PA. Sonic Hedgehog opposes epithelial cell cycle arrest. J Cell Biol 1999; 147: 71-76.
20. Hutchin ME, Kariapper MST, Grachtchouk M, et al. Sustained hedgehog signaling is required for basal cell carcinoma proliferation and survival: Conditional skin tumorigenesis recapitulates the hair growth cycle. Genes Dev 2005; 19: 214-223.
21. Vorechovsky I, Unden AB, Sandstedt B, et al. Trichoepitheliomas contain somatic mutations in the overexpressed PTCH gene: Support for a gatekeeper mechanism in skin tumorigenesis. Cancer Res 1997; 57: 4677-4681.
22. Zedan W, Robinson PA, High AS. A novel polymorphism in the PTC gene allows easy identification of allelic loss in basal cell nevus syndrome lesions. Diagn Mol Pathol 2001; 10: 41-45.
23. Teh MT, Wong ST, Neill GW, et al. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 2002; 62: 4773-4780.
24. Lacour JP. Carcinogenesis of basal cell carcinomas: Genetics and molecular mechanisms. Br J Dermatol 2002; 146 (Suppl. 61): 17-19.
25. Katoh M, Katoh M. Human FOX gene family (review). Int J Oncol 2004; 25: 1495-1500.
26. Brancaccio A, Minichiello A, Grachtchouck M, et al. Requirement of the forkhead gene Fox1, a target of sonic hedgehog signaling, in hair follicle morphogenesis. Hum Mol Genet 2004; 13: 2595-2606.
27. Green CL, Khavari PA. Targets for molecular therapy of skin cancer. Semin Cancer Biol 2004; 14: 63-69.
28. Reifenberger J, Schon MP. Cutaneous epithelial tumours. Molecular biology and pathogenesis-based therapy. Hautarzt 2003; 54: 1164-1170.
29. Miller SJ, Yu TC. Cyclopamine as a potential therapeutic agent for treatment of tumors related to hedgehog pathway mutations. Dermatol Surg 2002; 28: 187.
30. Chen JK, Taipale J, Cooper MK, et al. Inhibition of hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 2002; 16: 2743-2748.
31. McFerren MA. Useful plants of dermatology. VII. The false hellebore (Veratrum californicum). J Am Acad Dermatol 2006; 54: 718-720.
32. Yanai K, Nagai S, Wada J, et al. Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. J Surg Oncol 2007; 95: 55-62.
33. Meth MJ, Weinberg JM. Cyclopamine: Inhibiting hedgehog in the treatment of psoriasis. Cutis 2006; 78: 185-188.
34. Reifenberger J, Wolter M, Knobbe CB, et al. Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 2005; 152: 43-51.
35. Salto-Tellez M, Peh BK, Ito K, et al. RUNX3 protein is overexpressed in human basal cell carcinomas. Oncogene 2006; 25: 7646-7649.